Antenatal testing is the collection of screening tests, diagnostic tests, and monitoring checks performed during pregnancy to assess the health of both the pregnant person and the developing baby. These tests range from routine blood draws at your first prenatal visit to specialized ultrasounds and genetic screens spread across all three trimesters. Some estimate risk, others give definitive answers, and a few monitor the baby’s well-being in the final weeks before delivery.
Screening Tests vs. Diagnostic Tests
The most important distinction in antenatal testing is between screening and diagnostic tests, because they answer fundamentally different questions. A screening test estimates whether your risk of a particular condition is higher or lower than average. It does not give you a yes-or-no answer. A diagnostic test does: it confirms or rules out a specific condition.
Screening tests are offered to people who have no signs or symptoms of a problem. They cast a wide net. Because they deal in probabilities, they can produce false positives (flagging a risk that isn’t actually there) or false negatives (missing a real condition). A positive screening result doesn’t mean something is wrong. It means the next step is usually a diagnostic test to find out for certain.
Routine Tests in Early Pregnancy
At your first prenatal visit, your provider will order a standard panel of lab work. This typically includes a complete blood count, blood typing (including Rh factor), a urine test, and a urine culture. You’ll also be screened for infections that can affect pregnancy, including rubella, hepatitis B and C, HIV, tuberculosis, and syphilis. If you’re under 25 or at increased risk for sexually transmitted infections, you’ll be tested for chlamydia and gonorrhea as well. These infections are screened early because treating them sooner reduces the chance of complications for you and the baby.
Syphilis testing is now recommended three times during pregnancy: at the first prenatal visit, again in the third trimester, and at delivery.
First Trimester Screening
Between about weeks 11 and 14, you may be offered a nuchal translucency ultrasound. This scan measures a small pocket of fluid at the back of the baby’s neck. A measurement up to about 3 millimeters is considered low risk. The thicker that measurement compared to other babies at the same gestational age, the higher the statistical risk for certain genetic conditions like Down syndrome. This ultrasound is often combined with a blood test to refine the risk estimate further.
Another option during the first trimester or early second trimester is cell-free DNA screening, sometimes called NIPT (noninvasive prenatal testing). This blood test analyzes tiny fragments of the baby’s DNA circulating in the pregnant person’s bloodstream. For Down syndrome specifically, the positive predictive value ranges from roughly 86% in lower-risk pregnancies to about 98% in higher-risk pregnancies. For other common chromosomal conditions like trisomy 18 and trisomy 13, the accuracy is somewhat lower. NIPT is highly sensitive, but it is still a screening test. A positive result should be followed up with a diagnostic procedure before making any decisions.
Diagnostic Procedures: CVS and Amniocentesis
When screening results suggest an elevated risk, two procedures can provide a definitive genetic diagnosis. Chorionic villus sampling (CVS) is typically performed between weeks 10 and 13. It involves collecting a tiny sample of placental tissue. Amniocentesis is usually done between weeks 15 and 20 and involves withdrawing a small amount of amniotic fluid with a needle guided by ultrasound.
Both procedures carry a small risk of miscarriage, though that risk is lower than many people expect. A large meta-analysis covering more than 63,000 amniocentesis procedures and 13,000 CVS procedures found that the procedure-related miscarriage risk was about 0.3% for amniocentesis and about 0.2% for CVS. When researchers compared outcomes only among women with similar risk profiles, the additional risk from amniocentesis dropped to roughly 0.12%, and the risk from CVS was essentially negligible. These numbers are considerably lower than the 1-in-200 or 1-in-100 figures that were quoted for decades.
Gestational Diabetes Screening
Most pregnant people are screened for gestational diabetes between weeks 24 and 28. The initial test is a glucose challenge: you drink a sugary liquid, and your blood sugar is measured one hour later. If your result falls above a threshold (typically somewhere between 130 and 140 mg/dL, depending on your provider’s protocol), you move on to a longer glucose tolerance test. That second test requires fasting overnight, then having your blood drawn multiple times over three hours after drinking another glucose solution.
If you’re considered high risk for gestational diabetes based on factors like family history, weight, or a previous gestational diabetes diagnosis, your provider may offer the longer test earlier in pregnancy.
Third Trimester Testing
Late pregnancy brings its own set of tests. At 36 or 37 weeks, you’ll be screened for group B streptococcus (GBS), a common bacterium that can live in the vagina or rectum without causing any symptoms in adults but can be dangerous for a newborn during delivery. The test is a simple swab. If you test positive, you’ll receive antibiotics through an IV during labor to protect the baby.
For pregnancies considered higher risk, whether due to conditions like preeclampsia, diabetes, or being past the due date, your provider may order additional monitoring to check how the baby is doing. Two common tools are the non-stress test and the biophysical profile.
Non-Stress Test and Biophysical Profile
A non-stress test tracks the baby’s heart rate in response to its own movements, typically for about 20 to 40 minutes while you sit or recline with a monitor strapped to your belly. A healthy baby’s heart rate speeds up when it moves.
A biophysical profile goes further. It combines a non-stress test with an ultrasound that evaluates four additional things: fetal breathing movements, body movements, muscle tone, and the volume of amniotic fluid surrounding the baby. Each of these five components is scored as either 2 (present and normal) or 0 (absent or insufficient). A total score of 8 or 10 indicates the baby is doing well. A score of 6 is borderline, and 4 or below is considered abnormal and typically prompts further action, which could mean closer monitoring or, in some cases, early delivery.
What to Expect Practically
Most antenatal tests require little or no preparation. Blood draws, swabs, and standard ultrasounds are straightforward. The glucose tolerance test is the main exception: you’ll need to fast overnight before the three-hour version, and many people find the sugary drink unpleasant. For early ultrasounds (before about 12 weeks), you may be asked to come with a full bladder, which helps create a clearer image.
No single test gives a complete picture of a pregnancy. Antenatal testing works as a layered system, with routine screenings catching common issues, specialized tests following up on anything unusual, and late-pregnancy monitoring keeping tabs on the baby’s condition as delivery approaches. Your provider will recommend specific tests based on your age, health history, and how the pregnancy is progressing, and you can decline any test you choose not to have.